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Calcifying epithelial odontogenic tumor (CEOT) or
Pindborg tumor is a rare, benign neoplasm of odon-
togenic origin, which accounts for about 0.4% to 3%
of all odontogenic tumors.1,2 This lesion was de-
scribed as a distinct entity for the first time by Pind-
borg in 1955 and was designated as Pindborg tumor in
1967.3,4 Intraosseous location of the tumor is the
most common, accounting for about 94% of the cases
reported thus far, but an extraosseous or peripheral
variant was also described by Pindborg in 1966 and
corresponds to approximately 6% of all cases of
CEOT.3,5,6
Clinically, peripheral CEOT appears as an asymp-
tomatic lesion of firm consistency in the anterior
gingiva, which may or may not show an ulcerated
surface due to secondary trauma, and might be con-
fused with fibrous hyperplasia, pyogenic granuloma,
or peripheral giant cell lesion. Because this variant is
extremely rare, its incidence and prevalence are still
unknown, although the few cases reported in the
literature indicate a discrete predominance in men
with a mean age of 34.4 years.1,7
The treatment of choice for CEOT ranges from
simple enucleation to radical resection in some cases
of invasive intraosseous CEOT. We present here an
unusual case of peripheral CEOT associated with gen-
eralized drug-induced gingival growth in an 18-year-
old patient, and discuss the main aspects of this very
rare variant reported in the literature.
Report of a Case
Patient E.L.S., an 18-year-old man with melanoderma, was
seen at the Discipline of Periodontics, Universidade Potiguar,
with complaints of generalized gingival growth. The medical
history showed that the patient had mental disease and epi-
lepsy, had been using gardenal (phenobarbital, 100 mg/day)
and hydantal (phenytoin, 100 mg/day) for about 10 years, and
was currently treated with tegretol (carbamazepine, 200 mg/
day). Intraoral clinical examination showed asymptomatic, hy-
perplastic, generalized gingival growth of fibrous consistency
with a pale pink color and bleeding upon probing, as well as
numerous deposits of dental biofilm and dental calculus. The
buccal surfaces of the anterior teeth were more affected,
mainly in the papillae, partially covering the teeth and forming
pseudopockets (Figs 1, 2). The patient also presented a lesion
clinically diagnosed as pyogenic granuloma that filled a caries
lesion located in the lower right first molar (Fig 3). Radio-
graphic examination showed no signs of periodontitis. Based
*PhD Student in Oral Pathology, Universidade Federal do Rio
Grande do Norte, Natal-RN, Brazil.
†PhD Student in Oral Pathology, Universidade Federal do Rio
Grande do Norte, Natal-RN, Brazil.
‡PhD Student in Oral Pathology, Universidade Federal do Rio
Grande do Norte, and Professor of the Discipline of Periodontics,
Universidade Potiguar, Natal-RN, Brazil.
§Dentistry Student, Universidade Potiguar, Natal-RN, Brazil.
¶Dentistry Student, Universidade Potiguar, Natal-RN, Brazil.
Professor, Discipline of Stomatology, Universidade Potiguar, Na-
tal-RN, Brazil.
#Professor, Postgraduate Program in Oral Pathology, Univer-
sidade Federal do Rio Grande do Norte, Natal-RN, Brazil.
Address correspondence and reprint requests to Dr Galvão:
Departamento de Odontologia, Programa de Pós-Graduação em
Patologia Oral, Universidade Federal do Rio Grande do Norte, Av.
Senador Salgado Filho 1787, Lagoa Nova, Cep 59056-000 Natal / RN
– Brasil; e-mail: gordonnunez@patologiaoral.com.br
© 2007 American Association of Oral and Maxillofacial Surgeons
0278-2391/07/6502-0033$32.00/0
doi:10.1016/j.joms.2006.05.045
DA SILVEIRA ET AL 341
on these findings, a clinical diagnosis of drug-induced gingival
growth was made.
Treatment was then initiated that consisted of basic pro-
cedures for the removal and control of the biofilm and
dental calculus, including scaling and crown planing and
oral hygiene instructions. In addition, conventional gingivo-
plasty in the anterior areas and internal bevel gingivoplasty
in the posterior areas were performed in various steps. The
surgical specimens were sent to the Pathological Anatomy
Service of the Discipline of Oral Pathology, Universidade
Federal do Rio Grande do Norte, where they were pro-
cessed and stained with hematoxylin and eosin. Light mi-
croscopy analysis of the anterior areas of the maxilla and
mandible, as well as of the posterior areas of the maxilla and
left side of the mandible showed histopathological data
compatible with drug-induced gingival growth. However, in
the case of the lesion located in the region of the lower right
first molar with a clinical diagnosis of pyogenic granuloma,
the histological sections showed fragments of a benign
neoplasm of odontogenic origin characterized by the pro-
liferation of hyperpigmented epithelial cells arranged in
islets and chains and foci of basophilic material resembling
dystrophic calcifications, some of them exhibiting concen-
tric arrangements characteristic of Liesegang rings, in addi-
tion to the presence of amorphous eosinophilic material
within a tumor stroma consisting of well-vascularized loose
fibrous connective tissue, which formed the basis of a mono-
nuclear inflammatory infiltrate (Figs 4-6). The lesion was lined
with orthokeratinized or hyperparakeratinized stratified pavi-
mentous epithelium of the oral mucosa, which showed foci of
acanthosis, hydropic degeneration, spongiosis, and some large
oral filiforms projections at a right angle to the direction of the
connective tissue. Based on these findings, the diagnosis of
CEOT was made. The patient is currently being followed up
and shows no signs of recurrence.
Discussion
CEOT is defined by the World Health Organiza-
tion as a benign tumor arising from odontogenic
epithelium without the participation of ectomesen-
chyme, which shows an intra- or extraosseous lo-
cation and corresponds to approximately 1% of all
odontogenic tumors. The intraosseous location is
the most common one and can even cause local
FIGURE 1. Facial view of the anterior teeth showing evident gingival
overgrowth.
Da Silveira et al. CEOT Associated With Drug-induced Gingival
Growth. J Oral Maxillofac Surg 2007.
FIGURE 3. Lingual view of the region in which the Pindborg’s Tumor
was removed. The larger nodular mass between the first and second
molars can been observed.
Da Silveira et al. CEOT Associated With Drug-induced Gingival
Growth. J Oral Maxillofac Surg 2007.
FIGURE 4. A low-power view of the gingival mucosa fragment lined
by parakeratinized stratified squamous epithelium present in the lamina
propria as irregular strands and nests of epithelial eosinophilic cells
and amyloidlike material (hematoxylin-eosin, 40).
Da Silveira et al. CEOT Associated With Drug-induced Gingival
Growth. J Oral Maxillofac Surg 2007.
FIGURE 2. Occlusal view of superior teeth showing the generalized
character of the gingival overgrowth.
Da Silveira et al. CEOT Associated With Drug-induced Gingival
Growth. J Oral Maxillofac Surg 2007.
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invasion. The peripheral or extraosseous variant is
less frequent, accounting for only 6% of CEOT.1,8
Only 14 cases of peripheral CEOT have been re-
ported in the scientific literature from its first de-
scription by Pindborg in 1996, to 2003. The case
described here is quite rare and unusual because of
the association of peripheral CEOT with drug-in-
duced gingival growth, a fact not yet reported in
the literature.
According to Anavi et al,8 some clinical differ-
ences exist between central and peripheral CEOTs
because the peripheral form is more frequently
observed in young patients with a mean age of 34
years, whereas central tumors predominate in
adults with a mean age of 44 years. Peripheral
CEOTs more frequently affect the region of the
premolars (71%) and are generally small (1.2 to 3
cm) and indolent, although Ching et al9 reported a
case of extraosseous CEOT with progressive inva-
sion towards the maxillary sinus. In contrast, cen-
tral CEOTs are more often located in the posterior
region of the maxilla (64%). According to Bouckaert
et al,4 the biological behavior of these tumors, al-
though benign and of slow growth, can be locally
aggressive, with the authors reporting a case of
central CEOT invading the maxillary and ethmoidal
sinus with intracranial extension, causing compres-
sion and brain abscess.
In fact, of the 14 cases of peripheral CEOT re-
ported thus far, 7 were detected in women and 6 in
men, while in 1 case the gender was not specified.
Age ranged from 12 to 64 years, with a peak inci-
dence in the third decade of life, and a mean age of
34 years. Eight of these cases were located in the
mandibular gingiva and 6 in the maxillary gingiva
(Table 1). The present case differs in some aspects
from those reported in the literature because the
lesion was observed in an 18-year-old male patient.
However, with respect to location, ie, the mandib-
ular gingiva, the present case was similar to most
reported cases.
The histogenesis of peripheral CEOTs is uncer-
tain, but it has been suggested that the lesion arises
from remnants of the dental lamina or from basal
cells of the oral epithelium.5 Bouckaert et al4 re-
ported that these tumors probably originate from
oral epithelium.
Clinically, peripheral CEOT manifests as a small
well-circumscribed mass of slow growth, which is
generally sessile and asymptomatic but can cause
pain in some cases.6,7 In the present case, an asso-
ciation with drug-induced gingival growth was ob-
served, but the lesion was sessile and located in the
region of the lower right first molar, showing a
color similar to that of the mucosa and without
defined limits between the lesion and the drug-
induced gingival growth, thus being clinically con-
fused with pyogenic granuloma.
The histopathological spectrum of CEOT in-
cludes nests, islets, or masses of polyhedric epithe-
lial cells containing eosinophilic cytoplasm and a
hyperpigmented nucleus, with intercellular bridges
being observed.1,8,17 Other characteristics include
variable amounts of amyloid material and calcifica-
tions, some showing concentric arrangements
called Liesegang rings. Philipsen and Reichart1 sug-
gested that despite histochemical, immunohisto-
chemical, and ultrastructural studies, the nature of
the amyloid material is unknown and poorly under-
stood. In contrast, Yamaguchi et al18 proposed that
this material probably has a -protein conformation
FIGURE 6. Microphotography showing hyperpigmented epithelial
cells arranged in chains. Liesegang rings and foci of basophilic
material resembling dystrophic calcifications can been observed (he-
matoxylin-eosin, 100).
Da Silveira et al. CEOT Associated With Drug-induced Gingival
Growth. J Oral Maxillofac Surg 2007.
FIGURE 5. Calcifying epithelial odontogenic tumor exhibiting poly-
hedral epithelial cells with well-defined cellular borders and granular
eosinophilic cytoplasm (hematoxylin-eosin, 100).
Da Silveira et al. CEOT Associated With Drug-induced Gingival
Growth. J Oral Maxillofac Surg 2007.
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similar to the enamel matrix. Mesquita et al6
showed that the deposits of amyloid-like material
consist of extracellular matrix proteins such as fi-
bronectin and collagens I and III despite their dif-
ferent labeling intensity compared with nonamy-
loid extracellular matrix, a fact that led the authors
to conclude that this material in CEOTs represents
nonamyloid deposits in which the different groups
of the reported proteins correspond to extracellu-
lar matrix components.
Clear cells have also been observed in some
CEOTs as shown by Kumamoto et al19 and Mesquita
et al.6 These cells are generally characterized by a
vacuolated cytoplasm rich in glycogen and period-
ic-acid Schiff-positive material. When the lesion pre-
dominantly consists of clear cells, it might be con-
fused with salivary gland tumors such as
oncocytoma and mucoepidermoid carcinoma, in
addition to metastatic renal carcinomas, clear cell
odontogenic carcinomas, and peripheral ameloblas-
tomas.3,20
In agreement with Bouckaert et al,4 the morpho-
logical findings of peripheral CEOT led us to infer
that this lesion arises from the oral epithelium be-
cause the cells of these tumors often resemble
squamous cells. In the present case, the morpho-
logical characteristics observed left no doubt that
the lesion was a peripheral CEOT because we ob-
served proliferation of hyperpigmented epithelial
cells arranged in islets and chains, foci of basophilic
material resembling dystrophic calcifications, some
of them showing concentric arrangements charac-
teristic of Liesegang rings, in addition to the pres-
ence of amorphous eosinophilic material and the
absence of radiographic signs.
Various lesions that occur in the gingiva can be
confused with peripheral CEOT, including fibrous
hyperplasia, pyogenic granuloma, peripheral giant
cell lesion, and peripheral ossifying fibroma.6,21 In
the present case, the clinical hypothesis for the
general clinical presentation was drug-induced gin-
gival growth based on the fact that the patient had
reported the use of drugs for the treatment of
epilepsy inducing this condition and had been sub-
mitted to gingivoplasty in other regions where the
histopathological exam showed morphological
findings compatible with drug-induced gingival hy-
perplasia. However, the diagnostic hypothesis for
the lesion located in the lower right first molar was
pyogenic granuloma. The association between pe-
ripheral CEOT and drug-induced gingival growth is
still uncertain; however, its association with lesions
of odontogenic origin has already been reported,
eg, the adenomatoid odontogenic tumor that was
reported by Damm et al.21
Although some investigators have raised the hy-
pothesis that CEOT shows the same biological be-
havior as ameloblastoma, experience indicates that
the former is less aggressive.22 Thus, the treatment
of choice for this lesion has varied among authors,
ranging from simple enucleation and curettage to
block resection with safety margins. According to
Junqueira et al,23 conservative treatment (enucle-
ation and curettage) has shown a recurrence rate of
14%, while no relapse is observed when the treat-
ment is aggressive (block resection with safety mar-
gins). The choice of therapeutic conduct can be
based on the size of the tumor, with small lesions
being removed by simple enucleation, whereas in
the case of larger lesions, a radical or more aggres-
Table 1. CASES OF EXTRAOSSEOUS OR PERIPHERAL CALCIFYING EPITHELIAL ODONTOGENIC TUMOR (CEOT)
REPORTED IN THE LITERATURE (N  14)
Reference Age (Years) Gender Located in Gingival Area
Pindborg (1966)10 29 F 22
Pindborg (1966)10 16 F 41, 42
Decker and Laffite (1967)11 40 M Mandible, premolar
Abrams and Howell (1967)12 16 F 41, 42
Patterson et al (1967)13 12 M 41 or 31
Krolls and Pindborg (1974)14 60 nd Anterior mandible
Wertheimer et al (1977)15 20 M 22-24
Ai-Ru et al (1982)16 32 F 34-36
Ai-Ru et al (1982)16 47 F 43, 44
Takeda et al (1983)5 31 F 16, 17
Houston and Fowler (1997)3 64 M 24
Houston and Fowler (1997)3 27 M 44, 45
Ching et al (2000)9 23 M Left maxilla
Mesquita et al (2003)6 48 F 13
Abbreviations: F, female; M, male; nd, not determined.
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sive conduct may yield a better prognosis. In agree-
ment with the latter authors, the treatment of
choice in the present case was simple enucleation,
in view of the clinical diagnosis.
The description and discussion of rare lesions
such as peripheral CEOT is of the utmost impor-
tance because these case reports permit the deter-
mination of the frequency and behavior of these
entities and better treatment. We report here for
the first time a rare case of peripheral CEOT asso-
ciated with drug-induced gingival growth.
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